
Ulfaz S 250mg/125mg Injection
Marketer
Soigner Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ulfaz S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this injection only under medical supervision; strictly adhere to the prescribed dosage schedule. Complete the entire course, even with symptom improvement, as premature cessation can compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your physician. Seek immediate medical attention for allergic reactions (rash, itching, swelling, dyspnea). Inform your doctor of all medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration will support recovery. Your doctor might order lab tests to monitor treatment response.
Primary Ingredients of Ulfaz S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Ulfaz S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ulfaz S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ulfaz S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ulfaz S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ulfaz S 250mg/125mg Injection works:
The injectable formulation Ulfaz S, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-action mechanism. Ceftriaxone, a crucial antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, complements this action by countering bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ulfaz S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Ulfaz S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remains scarce.
Breast feedingCAUTION
Administering Ulfaz S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ulfaz S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding Ulfaz S 250mg/125mg Injection use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Administering Ulfaz S 250mg/125mg Injection to individuals with severe hepatic impairment requires careful monitoring. Dosage modification may be necessary. Physician consultation is advised. Altering the Ulfaz S 250mg/125mg Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ulfaz S 250mg/125mg Injection :
Should you forget a scheduled dose of Ulfaz S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Ulfaz S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobial Agents |
